Alvotech Net Income
| ALVO Stock | USD 5.20 0.06 1.17% |
As of the 11th of February 2026, Alvotech shows the Downside Deviation of 3.2, mean deviation of 2.83, and Risk Adjusted Performance of 0.0428. Alvotech technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.
Alvotech Total Revenue |
|
Gross Profit | Profit Margin | Market Capitalization | Enterprise Value Revenue 4.9649 | Revenue |
| Last Reported | Projected for Next Year | ||
| Net Loss | -208.7 M | -219.1 M | |
| Net Loss | -462.2 M | -439.1 M | |
| Net Loss | -208.7 M | -219.1 M | |
| Net Loss | (0.78) | (0.82) | |
| Net Income Per E B T | 0.96 | 0.68 |
Alvotech | Net Income | Build AI portfolio with Alvotech Stock |
Evaluating Alvotech's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Alvotech's fundamental strength.
Latest Alvotech's Net Income Growth Pattern
Below is the plot of the Net Income of Alvotech over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Alvotech financial statement analysis. It represents the amount of money remaining after all of Alvotech operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Alvotech's Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Alvotech's overall financial position and show how it may be relating to other accounts over time.
| View | Last Reported (231.86 M) | 10 Years Trend |
|
Net Income |
| Timeline |
Alvotech Net Income Regression Statistics
| Arithmetic Mean | (240,898,358) | |
| Coefficient Of Variation | (47.18) | |
| Mean Deviation | 68,648,739 | |
| Median | (209,876,000) | |
| Standard Deviation | 113,644,640 | |
| Sample Variance | 12915.1T | |
| Range | 450.2M | |
| R-Value | (0.30) | |
| Mean Square Error | 12570.1T | |
| R-Squared | 0.09 | |
| Significance | 0.25 | |
| Slope | (6,658,662) | |
| Total Sum of Squares | 206641.7T |
Alvotech Net Income History
Other Fundumenentals of Alvotech
| Net Income From Continuing Ops | ||
| Net Income Applicable To Common Shares | ||
| Net Income Per Share | ||
| Net Income Per E B T |
Alvotech Net Income component correlations
Alvotech Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Alvotech is extremely important. It helps to project a fair market value of Alvotech Stock properly, considering its historical fundamentals such as Net Income. Since Alvotech's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Alvotech's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Alvotech's interrelated accounts and indicators.
Click cells to compare fundamentals
Will Biotechnology sector continue expanding? Could Alvotech diversify its offerings? Factors like these will boost the valuation of Alvotech. If investors know Alvotech will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Alvotech data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.58) | Earnings Share 0.23 | Revenue Per Share | Quarterly Revenue Growth 0.106 | Return On Assets |
Understanding Alvotech requires distinguishing between market price and book value, where the latter reflects Alvotech's accounting equity. The concept of intrinsic value - what Alvotech's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Alvotech's price substantially above or below its fundamental value.
Understanding that Alvotech's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Alvotech represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Alvotech's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Alvotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Alvotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Alvotech.
| 11/13/2025 |
| 02/11/2026 |
If you would invest 0.00 in Alvotech on November 13, 2025 and sell it all today you would earn a total of 0.00 from holding Alvotech or generate 0.0% return on investment in Alvotech over 90 days. Alvotech is related to or competes with Tilray, Phibro Animal, Evotec SE, UFP Technologies, Progyny, Select Medical, and Amphastar. Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide More
Alvotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Alvotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Alvotech upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.2 | |||
| Information Ratio | 0.0194 | |||
| Maximum Drawdown | 19.51 | |||
| Value At Risk | (5.51) | |||
| Potential Upside | 7.89 |
Alvotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Alvotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Alvotech's standard deviation. In reality, there are many statistical measures that can use Alvotech historical prices to predict the future Alvotech's volatility.| Risk Adjusted Performance | 0.0428 | |||
| Jensen Alpha | 0.0934 | |||
| Total Risk Alpha | (0.24) | |||
| Sortino Ratio | 0.0232 | |||
| Treynor Ratio | 0.2041 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Alvotech's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Alvotech February 11, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0428 | |||
| Market Risk Adjusted Performance | 0.2141 | |||
| Mean Deviation | 2.83 | |||
| Semi Deviation | 3.13 | |||
| Downside Deviation | 3.2 | |||
| Coefficient Of Variation | 2292.26 | |||
| Standard Deviation | 3.83 | |||
| Variance | 14.64 | |||
| Information Ratio | 0.0194 | |||
| Jensen Alpha | 0.0934 | |||
| Total Risk Alpha | (0.24) | |||
| Sortino Ratio | 0.0232 | |||
| Treynor Ratio | 0.2041 | |||
| Maximum Drawdown | 19.51 | |||
| Value At Risk | (5.51) | |||
| Potential Upside | 7.89 | |||
| Downside Variance | 10.26 | |||
| Semi Variance | 9.8 | |||
| Expected Short fall | (3.28) | |||
| Skewness | 0.8568 | |||
| Kurtosis | 1.57 |
Alvotech Backtested Returns
Alvotech secures Sharpe Ratio (or Efficiency) of -0.0105, which signifies that the company had a -0.0105 % return per unit of risk over the last 3 months. Alvotech exposes twenty-eight different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Alvotech's Risk Adjusted Performance of 0.0428, downside deviation of 3.2, and Mean Deviation of 2.83 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 0.77, which signifies possible diversification benefits within a given portfolio. As returns on the market increase, Alvotech's returns are expected to increase less than the market. However, during the bear market, the loss of holding Alvotech is expected to be smaller as well. At this point, Alvotech has a negative expected return of -0.0374%. Please make sure to confirm Alvotech's value at risk, as well as the relationship between the skewness and day median price , to decide if Alvotech performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.22 |
Weak predictability
Alvotech has weak predictability. Overlapping area represents the amount of predictability between Alvotech time series from 13th of November 2025 to 28th of December 2025 and 28th of December 2025 to 11th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Alvotech price movement. The serial correlation of 0.22 indicates that over 22.0% of current Alvotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.22 | |
| Spearman Rank Test | -0.16 | |
| Residual Average | 0.0 | |
| Price Variance | 0.05 |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Alvotech Accumulated Other Comprehensive Income
Accumulated Other Comprehensive Income |
|
Based on the recorded statements, Alvotech reported net income of (231.86 Million). This is 167.94% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The net income for all United States stocks is 140.61% higher than that of the company.
Alvotech Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Alvotech's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Alvotech could also be used in its relative valuation, which is a method of valuing Alvotech by comparing valuation metrics of similar companies.Alvotech is currently under evaluation in net income category among its peers.
Alvotech ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Alvotech's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Alvotech's managers, analysts, and investors.Environmental | Governance | Social |
Alvotech Fundamentals
| Return On Asset | 0.0198 | ||||
| Profit Margin | 0.12 % | ||||
| Operating Margin | (0.03) % | ||||
| Current Valuation | 2.83 B | ||||
| Shares Outstanding | 311.6 M | ||||
| Shares Owned By Insiders | 61.76 % | ||||
| Shares Owned By Institutions | 5.98 % | ||||
| Number Of Shares Shorted | 2.44 M | ||||
| Price To Sales | 2.79 X | ||||
| Revenue | 489.68 M | ||||
| Gross Profit | 318.74 M | ||||
| EBITDA | (32.27 M) | ||||
| Net Income | (231.86 M) | ||||
| Cash And Equivalents | 128.44 M | ||||
| Cash Per Share | 0.52 X | ||||
| Total Debt | 1.19 B | ||||
| Current Ratio | 0.86 X | ||||
| Book Value Per Share | (0.59) X | ||||
| Cash Flow From Operations | (236.84 M) | ||||
| Short Ratio | 4.36 X | ||||
| Earnings Per Share | 0.23 X | ||||
| Target Price | 22.17 | ||||
| Number Of Employees | 1.01 K | ||||
| Beta | 0.12 | ||||
| Market Capitalization | 1.6 B | ||||
| Total Asset | 1.22 B | ||||
| Retained Earnings | (2.44 B) | ||||
| Working Capital | 261.62 M | ||||
| Net Asset | 1.22 B |
About Alvotech Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Alvotech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Alvotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Alvotech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Pair Trading with Alvotech
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Alvotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alvotech will appreciate offsetting losses from the drop in the long position's value.Moving against Alvotech Stock
The ability to find closely correlated positions to Alvotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Alvotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Alvotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Alvotech to buy it.
The correlation of Alvotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Alvotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Alvotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Alvotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out To learn how to invest in Alvotech Stock, please use our How to Invest in Alvotech guide.You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.
Will Biotechnology sector continue expanding? Could Alvotech diversify its offerings? Factors like these will boost the valuation of Alvotech. If investors know Alvotech will grow in the future, the company's valuation will be higher. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Alvotech data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth (0.58) | Earnings Share 0.23 | Revenue Per Share | Quarterly Revenue Growth 0.106 | Return On Assets |
Understanding Alvotech requires distinguishing between market price and book value, where the latter reflects Alvotech's accounting equity. The concept of intrinsic value - what Alvotech's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push Alvotech's price substantially above or below its fundamental value.
Understanding that Alvotech's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Alvotech represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. In contrast, Alvotech's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.